Under her leadership, the foundation is defining and codifying alternative commercialization pathways, and identifying new models to foster innovation. Mitchell was instrumental in founding the Kauffman Innovation Network and its iBridge Network, the Translational Medicine Alliance, the National Academies-based University—Industry Demonstration Partnership and the replication of innovator-based mentor programs across the U.S.
In addition, Mitchell serves on the boards of Gazelle Growth in Denmark and the University of Kansas Institute for Commercialization.
She is also an advisor to the Institute for Pediatric Innovation. Before joining Kauffman, Mitchell spent 20 years in global executive roles at Aventis, Quintiles and Marion Laboratories and ran an electronic clinical trials consulting business in support of global pharmaceutical clients.
